lobbying_activities: 834376

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
834376	5f91dc15-fdf6-447f-bfbd-f8fac7f7f283	Q3	FIERCE, ISAKOWITZ & BLALOCK	44812	COALITION FOR A COMPETITIVE PHARMACEUTICAL MARKET	2009	third_quarter	PHA	Generic Biologics: -S726/H.R.1427: Promoting Innovation and Access to Life-Saving Medicine Act -H.R.1548: Pathway for Biosimilars Act -S.1679 Affordable Health Choices Act Americas Health Future Act of 2009 -Biosimilar Reimbursement Utilization Equity Amendment -Limited Exception to Anti-Kickback Statute to Waive Co-payments For Generic Drugs	HOUSE OF REPRESENTATIVES,SENATE	50000		0	0	2009-10-18T18:50:55-04:00